GLOL BIOE Share Price Swiss Exchange
Equities
OXGBE
FR0011052257
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | 17.5L 18.97L 16Cr | Sales 2025 * | 20.5L 22.23L 18Cr | Capitalization | 3.59Cr 3.89Cr 323.56Cr |
---|---|---|---|---|---|
Net income 2024 * | -60L -65.05L -54Cr | Net income 2025 * | -80L -86.73L -72Cr | EV / Sales 2024 * | 24.3 x |
Net Debt 2024 * | 67L 72.64L 60Cr | Net Debt 2025 * | 1.4Cr 1.51Cr 125.76Cr | EV / Sales 2025 * | 24.3 x |
P/E ratio 2024 * |
-3.6
x | P/E ratio 2025 * |
-3.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.03% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Delcourt
FOU | Founder | 53 | 06/08/06 |
Samuel Dubruque
DFI | Director of Finance/CFO | - | 01/14/01 |
Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pierre Levi
BRD | Director/Board Member | 69 | 18/19/18 |
Marc Delcourt
FOU | Founder | 53 | 06/08/06 |
Director/Board Member | 66 | 18/01 |
1st Jan change | Capi. | |
---|---|---|
+7.01% | 22TCr | |
+11.01% | 19TCr | |
+19.20% | 14TCr | |
+30.79% | 11TCr | |
+1.10% | 6.46TCr | |
+13.95% | 5.24TCr | |
-0.16% | 4.85TCr | |
-6.20% | 3.8TCr | |
+0.91% | 3.56TCr |
- Stock Market
- Equities
- ALGBE Stock
- OXGBE Stock